1. Log on to the website of your local human resources and social security bureau or the online service platform of medical insurance card, enter the website, enter your name and ID number, and query the payment and consumption records of medical insurance.
2. Employees can call the social security hotline 12333 to check the status of five social security contributions and the accumulated amount in their personal pension accounts.
3. Every time you go to a pharmacy to buy medicine or pay for medical expenses at a hospital, you will get an invoice. You can view the following consumption information in detail, including the balance of payment in previous years and the balance of the current year.
Operating environment: UC Browser version 13.6, Huawei nove6se, National Health Insurance Service Platform version 1.3
:About the Medical Protection Bureau
After the establishment of the Medical Protection Bureau, it will become the most concerned government department of pharmaceutical companies and medical equipment companies. There are three reasons:
1. Market Access
What is market access for the domestic pharmaceutical industry? We can narrowly understand: bidding, health insurance.
If the drugs cannot pass the bidding, they will lose the whole hospital market. In addition, if the drugs cannot enter the medical insurance catalog, even if they pass the bidding, it will have a great impact on their market.
Bidding and the health insurance catalog are both market access, and now that both rights are in the hands of the Health Insurance Bureau, their importance cannot be overstated.
2. Strict control of drug use
Medicare cost control clearly remains the key word for 2018. Under the big action of Medicare cost control, for pharmaceutical companies, entering the catalog is only a threshold, hospital access and Medicare payment standards are the top priority.
Medicare is empowered to control costs at the source and has direct control over previously high-dose drugs and ancillary medicines. In addition, under Medicare payment standards, hospitals will be prompted to treat patients with the least costly drugs based on rational drug use. In the future, the interests of all parties in the Medicare environment will be more obvious game.
3. Directly determine the price of drugs
Previously, drug prices were priced by the National Development and Reform Commission, the Ministry of Human Resources and Social Security was responsible for the health insurance catalog, and the Health and Family Planning Commission was responsible for bidding and purchasing, and ultimately paid for by health insurance. Those who spent the money couldn't talk about prices and standardized use, leading to increasing pressure on health insurance.
Today, the Bureau of Medical Protection has taken over the bidding and purchasing of medicines, reflecting on the one hand the principle of "who pays, who makes the market". On the other hand, in the actual health insurance funds, the winning price of drugs will be closely linked to the health insurance payment standard, so as to maximize the interests of all parties.
In this case, hospitals or medical alliances can negotiate drug prices based on health insurance payment standards. They can even commission a third-party platform to negotiate drugs with local health insurance bureaus. There is only one ultimate goal. To reduce drug prices and maximize benefits based on health insurance payment standards.
It can be said that medical insurance will directly affect the fate of pharmaceutical companies and even businesses from a number of angles. By the Medical Security Bureau at the helm.